Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Change in Receivables (2022 - 2025)

Core Laboratories (CLB) has 4 years of Change in Receivables data on record, last reported at -$3.1 million in Q3 2025.

  • For Q3 2025, Change in Receivables fell 227.03% year-over-year to -$3.1 million; the TTM value through Sep 2025 reached -$5.2 million, down 135.01%, while the annual FY2024 figure was $3.6 million, 37.97% up from the prior year.
  • Change in Receivables reached -$3.1 million in Q3 2025 per CLB's latest filing, down from -$2.2 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $6.7 million in Q4 2022 and bottomed at -$5.8 million in Q4 2024.
  • Average Change in Receivables over 4 years is $1.1 million, with a median of $1.2 million recorded in 2022.
  • Peak YoY movement for Change in Receivables: surged 182.08% in 2024, then tumbled 404.66% in 2025.
  • A 4-year view of Change in Receivables shows it stood at $6.7 million in 2022, then decreased by 17.91% to $5.5 million in 2023, then crashed by 206.54% to -$5.8 million in 2024, then surged by 46.97% to -$3.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Receivables were -$3.1 million in Q3 2025, -$2.2 million in Q2 2025, and $5.9 million in Q1 2025.